CVI Holdings’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$5.44M Buy
+679,739
New +$5.44M 4.69% 3